Chemist Warehouse Could Benefit from Loyalty Opportunity, Jarden Research Says

MT Newswires Live
08/08

Implementing a loyalty program could lift sales and boost margin for Sigma Healthcare (ASX:SIG) subsidiary Chemist Warehouse amid growing competition, Jarden Research said in a Thursday note.

The growth of Chemist Warehouse is attributed to its value-led strategy, and Jarden sees an opportunity for the pharmacy retailer through a loyalty program as it looks to increase adjacencies, grow share of wallet and improve terms, as well as expand in new markets.

A loyalty program has the potential to boost sales by over 2% in the first year, and drive margin and total addressable market longer term, positioning Sigma Healthcare as the Australian health leader, according to the investment and advisory firm.

Jarden maintained its overweight rating and price target of AU$3.30 for Sigma Healthcare.

Sigma Healthcare shares rose more than 1% in midday trade on Friday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10